BIOXYTRAN, INC Quarterly Return On Assets in % from Q4 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Bioxytran, Inc quarterly/annual Return On Assets history and growth rate from Q4 2012 to Q3 2024.
  • Bioxytran, Inc Return On Assets for the quarter ending September 30, 2024 was -2.17K %, a 22.9% decline year-over-year.
  • Bioxytran, Inc annual Return On Assets for 2023 was -2.54K %, a 463% decline from 2022.
  • Bioxytran, Inc annual Return On Assets for 2022 was -451 %, a 39.3% increase from 2021.
  • Bioxytran, Inc annual Return On Assets for 2021 was -742 %, a 72.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -2.17K -405 -22.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.54K -1.48K -140% Apr 1, 2024 Jun 30, 2024
Q1 2024 -3.01K -2.43K -419% Jan 1, 2024 Mar 31, 2024
Q4 2023 -2.54K -2.09K -463% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.77K -1.21K -219% Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.06K -520 -96.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -579 -66.9 -13.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -451 +292 +39.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -555 +94.7 +14.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -540 +348 +39.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -512 +1.51K +74.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -742 +1.97K +72.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -650 +2.83K +81.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -888 +3.11K +77.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -2.02K +559 +21.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.71K -928 -52.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -3.48K -2.15K -163% Jul 1, 2020 Sep 30, 2020
Q2 2020 -3.99K -4.1K -3996% Apr 1, 2020 Jun 30, 2020
Q1 2020 -2.58K -2.67K -3092% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.78K -1.7K -2030% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.32K -1.09K -469% Jul 1, 2019 Sep 30, 2019
Q2 2019 103 +297 Apr 1, 2019 Jun 30, 2019
Q1 2019 86.3 +576 Jan 1, 2019 Mar 31, 2019
Q4 2018 -83.7 +1.05K +92.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -233 +81.4 +25.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -195* +682 Apr 1, 2018 Jun 30, 2018
Q1 2018 -490 +68.7 +12.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -1.14K +24.1 +2.08% Oct 5, 2017 Dec 31, 2017
Q3 2017 -314 +1.24K +79.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -876 +300 +25.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -559 +2.57K +82.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -1.16K +1.11K +49% Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.55K +531 +25.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.18K +1.21K +50.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -3.13K -2.28K -269% Jan 1, 2016 Mar 31, 2016
Q4 2015 -2.27K -1.69K -290% Oct 1, 2015 Dec 31, 2015
Q3 2015 -2.08K -1.71K -456% Jul 1, 2015 Sep 30, 2015
Q2 2015 -2.39K -2.33K -3934% Apr 1, 2015 Jun 30, 2015
Q1 2015 -848 -577 -213% Jan 1, 2015 Mar 31, 2015
Q4 2014 -583 +159 +21.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -374 +535 +58.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -59.2 +967 +94.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -271 +749 +73.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -743 +39.1 +5.01% Oct 1, 2013 Dec 31, 2013
Q3 2013 -909 Jul 1, 2013 Sep 30, 2013
Q2 2013 -1.03K Mar 31, 2013 Jun 30, 2013
Q1 2013 -1.02K Jan 1, 2013 Mar 31, 2013
Q4 2012 -782 Oct 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.